Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 48 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 8846057

    Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  2. US 8841305

    Activators of the human pyruvate kinase M2 receptor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  3. US 8835613

    β-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  4. US 8828380

    Method for the treatment of pulmonary disease and method of producing proteins of use therein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  5. US 8829022

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  6. US 8828936

    Therapeutic use of SCGB3A2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  7. US 8822434

    Compositions and methods to treat cardiac diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  8. US 8822540

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  9. US 8821866

    Methods of treating and preventing colitis involving IL-13 and NK-T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  10. US 8822196

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  11. US 8816059

    Method for predicting and detecting tumor metastasis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  12. US 8815229

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  13. US 8809400

    Method to ameliorate oxidative stress and improve working memory via pterostilbene administration

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  14. US 8808684

    Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  15. US 8796302

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  16. US 8795964

    GRM3 mutations and use thereof for the diagnosis and treatment of melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  17. US 8795680

    Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  18. US 8795674

    Methods and compositions for modulating immune tolerance

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  19. US 8796291

    A3 adenosine receptor antagonists and partial agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  20. US 8790639

    Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  21. US 8790869

    Renal cell carcinoma biomarkers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  22. US 8791074

    Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  23. US 8790635

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  24. US 8785414

    Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.